Immunity boosters are a myth — why you shouldn’t believe claims that promise to fight Covid – ThePrint

Immunity boosters are a myth — why you shouldn’t believe claims that promise to fight Covid – ThePrint

One of the common misconceptions about vitamin supplements and other nutraceuticals is that they boost one’s immunity | Representational image | Polina Tankilevitch | Pexels Text Size: Bengaluru/New Delhi: With no scientifically established treatment for Covid-19 yet and a vaccine still in the trial stage, the buzzword during the past eight months has been ‘immune…

Continue Reading
Small children carry high amounts of virus; safely opening colleges will be a challenge – Reuters India

Small children carry high amounts of virus; safely opening colleges will be a challenge – Reuters India

FILE PHOTO: A teacher screens students as schools begin to reopen after the coronavirus disease (COVID-19) lockdown in Langa township in Cape Town, South Africa June 8, 2020. REUTERS/Mike Hutchings/File Photo(Reuters) – The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and…

Continue Reading
India Part of International Alliance GAVI’s New Coronavirus Global Vaccine Access Drive – News18

India Part of International Alliance GAVI’s New Coronavirus Global Vaccine Access Drive – News18

Image used for representation. The list of 92 AMC-eligible economies includes all economies with Gross National Income (GNI) per capita under USD 4,000 plus other World Bank International Development Association (IDA) eligible economies. PTI London Last Updated: July 31, 2020, 10:43 PM IST Share this: The international vaccine alliance GAVI has facilitated a new drive…

Continue Reading
Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine can – Times of India

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine can – Times of India

NEW DELHI: A subject expert committee on Covid-19 on Friday recommended to the country’s drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate. The recommendations of the committee at the Central Drugs Standard Control Organisation (CDSCO)…

Continue Reading